Learning objectives
After watching this webinar, participants will:
Need assessment and expected educational outcome
To better understand the pros and cons of individual anticoagulation compounds available since the introduction of NOACs, taking account of high risk groups, comorbidities, and drug limitations; as well as to understand the new class of anticoagulation drugs that is emerging and which require even more knowledge for appropriate application and selection of patients. Our webinar will address this growing multitude of choices to extend the clinical physician’s best options of anticoagulation treatments for their patients.
This programme is supported by Bayer AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
Main topic
Related Topics
Session information
This webinar is designed for cardiologists, neurologists, internists, primary care physicians specialised on stroke, and also those wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).